Published on 28 Mar 2024 on GuruFocus.com via Yahoo Finance
Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a biotechnology company focused on the discovery, development, and commercialization of RNA therapeutics for rare diseases and vaccines, has reported an insider transaction. According to a recent SEC filing, Chief Scientific Officer & COO Pad Chivukula sold 17,435 shares of the company on March 25, 2024.
Over the past year, the insider has sold a total of 111,000 shares and has not made any purchases of the company's stock. This latest transaction continues a pattern of insider sales at Arcturus Therapeutics Holdings Inc, with a total of 13 insider sells and no insider buys occurring over the same timeframe.